Figure 4: Distribution of Critical Shortages of Drugs Containing Controlled Substances by Therapeutic Class and Product Type, January 2001 through June 2013

Uploaded by	U.S. Government Accountability Office
License	United States Government Work
Comments	0
Favorites	0
Views	2,086
Date uploaded	2015-03-23
Tags	gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao15202, drugshortages, adhd, attentiondeficithyperactivitydisorder, api, activepharmaceuticalingredient, apq, aggregateproductionquota, arcos, automationofreportsandconsolidatedorderssystem, csa, controlledsubstancesact, dea, drugenforcementadministration, doj, departmentofjusticedssdrugshortagestaff, ems, emergencymedicalservices, fda, foodanddrugadministration, fdasia, foodanddrugadministrationsafetyandinnovationact, gpra, governmentperformanceandresultsactof1993, hhs, departmentofhealthandhumanservices, mou, memorandumofunderstanding, uudis, universityofutahdruginformationservice, yersqms, yearendreportingandquotamanagementsystem
Visibility	public